A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression.

ABSTRACT: We find significant evidence of the OVOL, AP1, STAT1, STAT3, and NFKB1 TFs having important roles in MET. We prioritize known gene/drug targets for follow-up in the clinic, and show that the AP1/MYC TF pair is a strong candidate for intervention. Examination of the effects of OVOL1 and OVOL2 overexpression common to prostate cancer and breast cancer models.

ORGANISM(S): Homo sapiens

SUBMITTER: Richard McEachin 

PROVIDER: E-GEOD-51975 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress